GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » Effective Interest Rate on Debt %

Immuno-Biological Laboratories Co (TSE:4570) Effective Interest Rate on Debt % : 0.50% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Immuno-Biological Laboratories Co's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was 円1.2 Mil. Immuno-Biological Laboratories Co's average total debt for the quarter that ended in Dec. 2023 was 円237.5 Mil. Therefore, Immuno-Biological Laboratories Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 0.50%.


Immuno-Biological Laboratories Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Immuno-Biological Laboratories Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co Effective Interest Rate on Debt % Chart

Immuno-Biological Laboratories Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.19 0.38 0.40 0.46

Immuno-Biological Laboratories Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.45 0.45 0.45 0.50

Competitive Comparison of Immuno-Biological Laboratories Co's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuno-Biological Laboratories Co's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Effective Interest Rate on Debt % falls into.



Immuno-Biological Laboratories Co Effective Interest Rate on Debt % Calculation

Immuno-Biological Laboratories Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Mar. 2022 )+Total Debt  (A: Mar. 2023 ))/ count )
=-1  *  -1.073/( (233.998+234.99)/ 2 )
=-1  *  -1.073/234.494
=0.46 %

where

Total Debt  (A: Mar. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=104.99 + 129.008
=233.998

Total Debt  (A: Mar. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=99.101 + 135.889
=234.99

Immuno-Biological Laboratories Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Sep. 2023 )+Total Debt  (Q: Dec. 2023 ))/ count )
=-1  *  -1.18/( (237.986+236.984)/ 2 )
=-1  *  -1.18/237.485
=0.50 %

where

Total Debt  (Q: Sep. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=97.125 + 140.861
=237.986

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=90.843 + 146.141
=236.984

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Immuno-Biological Laboratories Co  (TSE:4570) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Immuno-Biological Laboratories Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuno-Biological Laboratories Co (TSE:4570) Business Description

Traded in Other Exchanges
N/A
Address
1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co., Ltd. focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co (TSE:4570) Headlines

No Headlines